Arrowhead Pharmaceuticals Inc (ARWR)
13.85
+0.70 +5.32%
NASDAQ
Oct 16, 16:59
Delayed 2m
USD
View All Key Stats
ARWR Key Stats
| Income Statement | |
| Revenue (TTM) | 13.60M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.69 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -54.42M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -2.15K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 1.219B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 81.80 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 11.92 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -14.61M |
| Return on Equity (TTM) | Upgrade |
View All ARWR News
ARWR News
-
WireHeadlineTime (ET)
-
Business Wire10/16 12:01
-
Yahoo10/16 06:14
-
SA Breaking News10/15 09:58
-
MT Newswires10/15 07:47
-
Business Wire10/15 07:30
-
Yahoo10/12 14:31
-
Yahoo10/11 15:58
-
Business Wire10/11 12:05
-
Yahoo10/10 10:30
-
Yahoo10/09 15:43
View All Events
ARWR Events
| Date | Type | Description |
|---|---|---|
| 12/12/2018 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018 |
| 12/12/2018 | Earnings | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release |
| 08/07/2018 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018 |
| 08/07/2018 | Earnings | Arrowhead Pharmaceuticals Inc Third Quarter Earnings Results in 2018 |
| 05/08/2018 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018 |
| 05/08/2018 | Earnings | Arrowhead Pharmaceuticals Inc Second Quarter Earnings Results in 2018 |
| 03/16/2018 10:00 PDT | Misc | Arrowhead Pharmaceuticals Inc Annual General Meeting in 2017 |
| 02/09/2018 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 02/09/2018 | Earnings | Arrowhead Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 12/12/2017 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
ARWR Fundamentals
Income Statement View Statement
ARWR Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ARWR One Page Reports
- One Page Report Download
ARWR Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 13.85 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.arrowheadpharma.com
- Investor Relations URL: http://ir.arrowheadpharma.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Dec. 12, 2018
- Last Earnings Release: Aug. 07, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
ARWR Excel Add-In Codes
- Name: =YCI("ARWR","name")
- Description: =YCI("ARWR","description")
- Sector: =YCI("ARWR","sector")
- Industry: =YCI("ARWR","industry")
- Est. Current Fiscal Year End: =YCI("ARWR","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ARWR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ARWR Tweets Stocktwits
Advertisement
